Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPYD | Q12882 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | THPO | P40225 | 1/20 | 0.45 |
| ▸ | MTOR | P42345 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | HBB | P68871 | 1/20 | 0.45 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5800398 | 0.79 | — | — | |
| SCHEMBL30850435 | 0.79 | DPYD (0.38) | DPYDGAAATAD2 | |
| SCHEMBL161148 | 0.77 | ATAD2 (0.54) | DPYDGAAATAD2ALDH1A1LMNA | |
| SCHEMBL2584919 | 0.76 | LMNA (0.52) | DPYDGAAATAD2ALDH1A1LMNA | |
| SCHEMBL2037916 | 0.76 | DPYD (0.46) | DPYDGAAATAD2ALDH1A1LMNA | |
| SCHEMBL6555485 | 0.76 | DPYD (0.52) | DPYDGAAATAD2ALDH1A1LMNA | |
| SCHEMBL5798297 | 0.76 | DPYD (0.46) | DPYDGAAATAD2ALDH1A1LMNA | |
| SCHEMBL4625879 | 0.76 | ALDH1A1 (0.52) | DPYDGAAATAD2ALDH1A1LMNA | |
| SCHEMBL4346481 | 0.74 | DPYD (0.45) | DPYDGAAATAD2ALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL22659843 | 0.74 | DPYD (0.45) | DPYDGAAATAD2ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240309370-A1 | METABOLIC DISORDER-ASSOCIATED TARGET GENE IRNA COMPOSITIONS AND METHODS OF USE THEREOF | BANK OF AMERICA, N.A. | 2024-09-19 | — | — | US | disclosed |